— Shorts

Short takes from the show

  • It’s not impossible. A mom rebuilding rare disease from scratch. #shorts

  • No family should have to do this alone. #shorts #raredisease

  • Why patient advocacy groups won’t share data and how to fix it. #shorts

  • The #1 gap holding back rare disease cures #shorts #biotech

  • The real reason biotech founders write grants #shorts

  • The Right Type of Capital in Biotech #shorts

  • How this parent found Nome after her son’s diagnosis #shorts

  • The science works. So why aren’t we curing anything? #shorts #biotech

  • Investor told her: stop using “rare disease” #shorts #biotech

  • Disability Is a Group Anyone Can Join #shorts

  • How Soon Can You Send Me Your Data? #shorts #rarediseases

  • Rare is Common. Why we’re all one diagnosis away. #shorts #rarediseaseawareness

  • Solving Rare

    Dr. Mimi Lee The Healer Rebuilding Rare Disease From Scratch

  • Jul 22, 2026

    Amy Krystosic: "Rare Is Common" — The Case for Precision Medicine's Future

    What does it actually take to build a foundation, a biotech company, and a clinical trial pathway for one of the rarest diseases in the world — while raising a child who lives with that same disease? In this episode of Solving Rare, Stevie Ringel sits down with Amy Krystosic — e

  • Jun 8, 2026

    David Apple: The Dad Who Built His Own Biotech to Treat His Son

    What does it actually take to build your own biotech company when your child is diagnosed with a rare disease and no treatment exists? In this episode of Solving Rare, Stevie Ringel sits down with David Apple — former tech founder, employee 15 at Typeform, employee 13 at Notion,

  • May 26, 2026

    Diagnosed at 17. Now I'm Building My Own Gene Therapy. | Welcome to Solving Rare

    At 17, I was diagnosed with a rare disease. When my younger sister was diagnosed with the same, I refused to accept that there was nothing we could do. So I went on a decade-long journey to figure out what was possible. I'm Stevie Ringel — a rare disease patient turned biotech b

Every engagement starts with a free eligibility assessment.

Get Started